GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » DeferredTaxAndRevenue

K Pharma (TSE:4896) DeferredTaxAndRevenue : 円0 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

K Pharma's current deferred tax and revenue for the quarter that ended in Mar. 2024 was 円0 Mil.

K Pharma DeferredTaxAndRevenue Historical Data

The historical data trend for K Pharma's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma DeferredTaxAndRevenue Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
DeferredTaxAndRevenue
- - -

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
DeferredTaxAndRevenue Get a 7-Day Free Trial - - - - -

K Pharma DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of K Pharma's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


K Pharma (TSE:4896) Business Description

Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines